189 related articles for article (PubMed ID: 16732286)
61. Structural insights into the clustering and activation of Tie2 receptor mediated by Tie2 agonistic antibody.
Jo G; Bae J; Hong HJ; Han AR; Kim DK; Hong SP; Kim JA; Lee S; Koh GY; Kim HM
Nat Commun; 2021 Nov; 12(1):6287. PubMed ID: 34725372
[TBL] [Abstract][Full Text] [Related]
62. Angiopoietins: a link between angiogenesis and inflammation.
Fiedler U; Augustin HG
Trends Immunol; 2006 Dec; 27(12):552-8. PubMed ID: 17045842
[TBL] [Abstract][Full Text] [Related]
63. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
64. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking.
Pfaff D; Fiedler U; Augustin HG
J Leukoc Biol; 2006 Oct; 80(4):719-26. PubMed ID: 16864601
[TBL] [Abstract][Full Text] [Related]
65. [Roles of angiopoietins family and its receptor in the pathogenesis and regulation of corneal neovascularization].
Wang X; Wang WT; Xu JJ; Hong JX
Zhonghua Yan Ke Za Zhi; 2008 Jul; 44(7):656-9. PubMed ID: 19040083
[TBL] [Abstract][Full Text] [Related]
66. Directed evolution of an angiopoietin-2 ligand trap by somatic hypermutation and cell surface display.
Brindle NP; Sale JE; Arakawa H; Buerstedde JM; Nuamchit T; Sharma S; Steele KH
J Biol Chem; 2013 Nov; 288(46):33205-12. PubMed ID: 24106271
[TBL] [Abstract][Full Text] [Related]
67. Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization.
Leppänen VM; Saharinen P; Alitalo K
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4376-4381. PubMed ID: 28396439
[TBL] [Abstract][Full Text] [Related]
68. Angiopoietins and Tie2 in health and disease.
Li LY; Barlow KD; Metheny-Barlow LJ
Pediatr Endocrinol Rev; 2005 Mar; 2(3):399-408. PubMed ID: 16429117
[TBL] [Abstract][Full Text] [Related]
69. Tie2 and Eph receptor tyrosine kinase activation and signaling.
Barton WA; Dalton AC; Seegar TC; Himanen JP; Nikolov DB
Cold Spring Harb Perspect Biol; 2014 Mar; 6(3):. PubMed ID: 24478383
[TBL] [Abstract][Full Text] [Related]
70. The structure of interleukin-2 complexed with its alpha receptor.
Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
[TBL] [Abstract][Full Text] [Related]
71. Cooperatively Responsive Peptide Nanotherapeutic that Regulates Angiopoietin Receptor Tie2 Activity in Tumor Microenvironment To Prevent Breast Tumor Relapse after Chemotherapy.
Zhang L; Qi Y; Min H; Ni C; Wang F; Wang B; Qin H; Zhang Y; Liu G; Qin Y; Duan X; Li F; Han X; Tao N; Zhang L; Qin Z; Zhao Y; Nie G
ACS Nano; 2019 May; 13(5):5091-5102. PubMed ID: 30986342
[TBL] [Abstract][Full Text] [Related]
72. Epithin/PRSS14 proteolytically regulates angiopoietin receptor Tie2 during transendothelial migration.
Kim C; Lee HS; Lee D; Lee SD; Cho EG; Yang SJ; Kim SB; Park D; Kim MG
Blood; 2011 Jan; 117(4):1415-24. PubMed ID: 21097670
[TBL] [Abstract][Full Text] [Related]
73. Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment.
Park JS; Kim IK; Han S; Park I; Kim C; Bae J; Oh SJ; Lee S; Kim JH; Woo DC; He Y; Augustin HG; Kim I; Lee D; Koh GY
Cancer Cell; 2016 Dec; 30(6):953-967. PubMed ID: 27960088
[TBL] [Abstract][Full Text] [Related]
74. Stage-dependent angiopoietin-Tie2 and nitric oxide signaling of erythrocytes in response to surgical trauma in head and neck cancer.
Wu HL; Chu YH; Tai YH; Tsou MY; Wu CH; Lo WL; Tai SK; Yeh CC; Lu CC
World J Surg Oncol; 2020 Aug; 18(1):209. PubMed ID: 32799882
[TBL] [Abstract][Full Text] [Related]
75. [Mechanisms and function of angiopoietin].
Liu S; Wang LY; Guo HY; Wu QX
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):273-5. PubMed ID: 14518437
[No Abstract] [Full Text] [Related]
76. Role of angiopoietin-2 in regulating growth and vascularity of astrocytomas.
Zadeh G; Koushan K; Baoping Q; Shannon P; Guha A
J Oncol; 2010; 2010():659231. PubMed ID: 20467564
[TBL] [Abstract][Full Text] [Related]
77. Imaging of Tie2 with a Fluorescently Labeled Small Molecule Affinity Ligand.
Koch PD; Ahmed MS; Kohler RH; Li R; Weissleder R
ACS Chem Biol; 2020 Jan; 15(1):151-157. PubMed ID: 31809013
[TBL] [Abstract][Full Text] [Related]
78. Identification and characterisation of chicken cDNAs encoding the endothelial cell-specific receptor tyrosine kinase Tie2 and its ligands, the angiopoietins.
Jones PF; McClain J; Robinson DM; Sato TN; Yancopoulos GD
Angiogenesis; 1998; 2(4):357-64. PubMed ID: 14517455
[TBL] [Abstract][Full Text] [Related]
79. TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells.
Tan S; Chen Y; Du S; Li W; Liu P; Zhao J; Yang P; Cai J; Gao R; Wang Z
Transl Oncol; 2022 Dec; 26():101539. PubMed ID: 36116242
[TBL] [Abstract][Full Text] [Related]
80. The renal angiopoietin/Tie2 system in lethal human sepsis.
Aslan A; Jongman RM; Moser J; Stegeman CA; van Goor H; Diepstra A; van den Heuvel MC; Heeringa P; Molema G; Zijlstra JG; van Meurs M
Crit Care; 2014 Mar; 18(2):423. PubMed ID: 24976393
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
